European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
The 26th Workshop on Methods in Clinical Cancer Research #MCCRWorkshop is underway. Supporting early-career researchers in developing robust, practice-changing clinical trials—one protocol at a time. @eortc@myesmo@AACR
🔴 Live from #EHA2026 Congress: EORTC-GIMEMA AML 21 Phase 3 trial analysis shows pre‑treatment HRQoL independently predicts survival in Older Adults with Acute Myeloid Leukemia, supporting the incorporation of PROs in fitness criteria.
@EHA_Hematology@FGIMEMA
📊 That's a wrap on #STATS2026!
Every June, non-statisticians come together to deepen their understanding of statistics in clinical research and cancer studies.
Thank you to all participants, speakers and faculty members!
#CancerResearch#ClinicalTrials#StatisticalMethods
📚 Congratulations to Yolande Lievens and fellow investigators on this important achievement, highlighting the value of prospective registries in advancing radiation oncology research.
🔗Publication: doi.org/10.1016/j.radonc.202…#E2RADIatE platform is supported by The Boots Group.
Just published in the #GreenJournal: Leveraging the potential of prospective registries for radiation oncology research: 5-year experience from the
@EORTC-ESTRO #radiotherapy infrastructure for Europe (E2-RADIatE) project
👉 Read the abstract: bit.ly/4vClkO9
🎉 LEGATO reaches a key milestone: 50% of patients enrolled.
EORTC is proud to coordinate this Horizon Europe project advancing research in recurrent glioblastoma.
📢Calling all early-career scientists!
Looking to showcase your work in cutaneous lymphomas? The Young Investigator Awards are now open as part of the EORTC‑CLTG Annual Meeting 2026.
📅 8–10 October in Berlin.
Apply by 14 June: eortc-cltg.org/abstracts/abs…
📊 #STATS2026 is underway!
🔍 Over the next few days, participants will gain a deeper understanding of key statistical principles and learn how to apply them in research and clinical practice.
#CancerResearch#ClinicalTrials#StatisticalMethods
Join our team in #Brussels!
The EORTC Projects and Services department is looking for a new Project Manager.
Do you have a master’s degree and 5 years of experience in a project management role? Are you looking for a new challenge?
Apply now: eortc.org/job/project-manage…#Jobs
Our Annual Report 2025 is now available, reflecting a year of progress, collaboration and continued commitment to independent clinical cancer research.
🔗 Read more in our news article and explore the full report: eortc.org/blog/2026/06/08/an…#CancerResearch
50 years of supporting independent cancer research.
Explore the story of the EORTC Cancer Research Fund, the people behind it, and its impact on cancer research since 1976.
🔗 eortcresearchfund.org/annive…#ECRF50
EORTC crossed the finish line at the #20kmBruxelles 🏃♀️🏃♂️
Great team effort from all colleagues!
With ECRF, the initiative continues beyond race day.
You can still support the effort.
👉 donate.eortcresearchfund.org…#RunforEORTC
Single-fraction or multi-fraction SBRT for oligometastatic disease?
EORTC SPRINT is exploring whether fewer treatment sessions could deliver the same efficacy while reducing burden for patients and healthcare systems.
#EORTC#SPRINT#ESTRO#E²-RADIatE #RadiationOncology#SBRT
🧪 This Bladder Cancer Awareness Month, discover STARBURST 1 (EORTC-2418), advancing precision research in muscle-invasive bladder cancer under the SPECTA platform.
Many thanks to the supporters contributing to this important research.
#EORTCgenitourinary#BladderCancer